BIORCHESTRA

South Korea
Yusong, Taejon-jikhalsi, South Korea

Company profile

BIORCHESTRA company profile

BIORCHESTRA is a biotech company that develops RNA-based therapeutics for treating neuroinflammatory diseases. They focus on changing the therapeutic paradigm from treating the symptoms to providing a fundamental cure for diseases. BIORCHESTRA develops neuroinflammatory disease therapeutics, with a particular emphasis on comprehensive patient care. BIORCHESTRA's complementary discovery platforms range from diagnosis to treatment monitoring.

Business identity

Contact email
[email protected]
Phone number
042-863-1013
Operating status
Active
Company type
For Profit
Employee range
51-100 employees
Revenue range
$1M-$10M
Founded
2016-10-18

Headquarters

Country code
KR
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Late Stage Venture
Funding rounds
4
Total equity funding
$60.8M
Last funding
Series C / $45.7M / 2022-02-22
Last equity funding
Series C / $45.7M
Investors
14
Lead investors
1
Founders
1
Articles
22

Founders and investors

Founders

Branden Ryu

Lead investors

Chong Kun Dang

Investors

IMM InvestmentLSK InvestmentQuantum Ventures KoreaSTIC InvestmentTIPS Program